Exelixis (EXEL) Depreciation & Amortization (CF) (2010 - 2026)

Exelixis (EXEL) recorded quarterly Depreciation & Amortization (CF) of $6.9 million in Q2 2026, little changed quarter-over-quarter from $6.9 million in Q1 2026, and down 5.41% on a YoY basis from $7.3 million in Q2 2025.

Exelixis (EXEL) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Exelixis' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $6.9 million for Q2 2026.

  • In Q2 2026, Depreciation & Amortization (CF) fell 5.41% year-over-year to $6.9 million; the TTM figure through Apr 2026 stood at $28.7 million (down 3.74% YoY), while the FY2026 annual figure was $29.1 million, up 0.87% from the prior year.
  • Depreciation & Amortization (CF) was $6.9 million for Q2 2026 at Exelixis, roughly flat from $6.9 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.6 million in Q1 2025 to a low of $4.5 million in Q2 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $6.6 million across 5 years, with a median of $6.9 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) jumped 207.92% in 2022, then declined 9.11% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.9 million in 2022, then increased by 9.75% to $6.5 million in 2023, then advanced by 14.22% to $7.5 million in 2024, then retreated by 0.43% to $7.4 million in 2025, then fell by 6.39% to $6.9 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $6.9 million (Q2 2026), $6.9 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 1,395.22
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 55.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 429,663.65
10 Exelixis 13.72 Bn 12.95 Bn 590.86 Mn 6.95 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 6.95 Mn
Apr 3, 2026 6.95 Mn
Jan 2, 2026 6.95 Mn
Jan 2, 2026 6.95 Mn
Oct 3, 2025 7.42 Mn
Oct 3, 2025 7.42 Mn
Jul 4, 2025 7.34 Mn
Jul 4, 2025 7.34 Mn
Apr 4, 2025 7.35 Mn
Apr 4, 2025 7.35 Mn
Jan 3, 2025 7.64 Mn
Jan 3, 2025 7.64 Mn
Sep 27, 2024 7.45 Mn
Sep 27, 2024 7.45 Mn
Jun 28, 2024 7.33 Mn
Jun 28, 2024 7.33 Mn
Mar 29, 2024 6.38 Mn
Mar 29, 2024 6.38 Mn
Dec 29, 2023 6.53 Mn
Dec 29, 2023 6.53 Mn